News
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Recursion Pharmaceuticals (RXRX – Research ...
Lupin is a global pharmaceutical company that was established in 1968 by Dr. Desh Bandhu Gupta. Currently headquartered in Mumbai, the company marks its presence across the US, Asia-Pacific, Latin ...
Swiss drugmaker Novartis said on Thursday it plans to spend $23 billion to build and expand 10 facilities in the U.S., as it grapples with renewed threats of drug import duties from the Trump ...
President Donald Trump says he plans to impose tariffs on pharmaceuticals "very shortly," in what could be the next phase of his sweeping overhaul of global trade.
The FTSE 100 tumbled 2.92 percent on Wednesday, shedding 231.05 points to close at 7,679.48 points as U.S. President Donald Trump's sweeping tariff plan officially came into effect, sending shockwaves ...
Pharmaceutical imports became the latest target for President Donald Trump’s tariffs, sending FTSE 100 drugmakers stock into ...
Taiwan Semiconductor Manufacturing could face a penalty of $1 billion or more to settle a U.S. export control investigation ...
The sudden fall in the stock markets today came after reports said Donald Trump could impose tariffs on the pharmaceutical ...
Wall Street suffers its worst day since 2020 but the White House tells investors to "trust in President Trump".
The imposition of US tariffs on a world-wide scale and at a high level could create recessionary trends across the globe, the ...
Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results